A neuroscientist explains the science of pain
In The Conversation's Curious Kids series, Dr. Yenisel Cruz-Almeida explains pain, how it travels, and why it's needed as a warning signal.
In The Conversation's Curious Kids series, Dr. Yenisel Cruz-Almeida explains pain, how it travels, and why it's needed as a warning signal.
New nonopioid compound shows potential for mitigating pain in preclinical animal models, human cells.
Dr. Rajesh Khanna is targeting key proteins involved in pain pathways, with a goal of safely “turning down the volume” on pain.
Dr. Christine Schmidt has been elected to the National Academy of Medicine, recognizing outstanding professional achievement and commitment to service in the fields of health and medicine.
Dr. Roger Fillingim was featured in article in The Hill examining how men and women experience pain differently.
MBI researchers Drs. Yenisel Cruz-Almeida and Kyle Allen will train postdoctoral fellows in effort to develop new non-opioid treatments for pain management.
With $10 million NIH grant, Drs. Kyle Allen and Yenisel Cruz-Almeida seek to explore pain pathways and create custom treatments.
Dr. Rajesh Khanna was featured for UF Innovate’s Tech Tuesday, discussing his work with the PATH Collaboratory toward non-addictive pain killers for patients with chronic pain.
MBI-led research team reports on potential way to regulate neuronal overactivity in quest for new therapies for chronic pain.
Honor recognizes Schmidt's work to help advance the fields of neural tissue engineering and wound healing and for her leadership in diversifying bioengineering.